Follow-up Line Therapy with Cabozantinib in locally advanced or metastatic Urothelial Carcinoma following Immunotherapy Failure

被引：0
|
作者：
Rexer, H. [1 ]
Bartsch, G. [2 ]
Ohlmann, C. -H. [3 ]
机构：
[1] AUO Geschaftsstelle, Schwarz, Germany
[2] Univ Klin Mainz UMM, Urolog Klin & Poliklin, LKP, Mainz, Germany
[3] Deutsch Krebsgesell eV, Organgruppensprecher Arbeitsgemeinschaft Urol Onk, Berlin, Germany
来源：
UROLOGE | 2020年 / 59卷 / 03期
关键词：
D O I：
10.1007/s00120-020-01145-5
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：388 / 389
页数：2
相关论文
共 50 条
  • [21] Cabozantinib in Combination with Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence
    Bergerot, Paulo
    Lamb, Peter
    Wang, Evelyn
    Pal, Sumanta K.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12) : 2185 - 2193
  • [22] Phase 1b trial of cabozantinib in combination with atezolizumab in patients with locally advanced or metastatic urothelial carcinoma or renal cell carcinoma
    Maia, Manuel Caitano
    Agarwal, Neeraj
    McGregor, Bradley
    Vaishampayan, Ulka
    Choueiri, Toni K.
    Green, Marjorie
    Hessel, Colin
    Scheffold, Christian
    Schwab, Gisela
    Powles, Thomas
    Pal, Sumanta
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [23] Match-adjusted indirect comparison of durvalumab and chemotherapy for locally advanced or metastatic urothelial carcinoma (UC) following failure of platinum-based therapy
    Hoyle, C. K.
    Klein, A. B.
    Patel, K. A.
    Shire, N.
    Wang, H.
    Chu, B. C.
    Ouwens, M.
    Nordstrom, B. L.
    Horne, L.
    Arkenau, H-T.
    ANNALS OF ONCOLOGY, 2018, 29 : 323 - 323
  • [24] Efficacy and tolerability of tremelimumab in locally advanced or metastatic urothelial carcinoma
    Sharma, Padmanee
    Sohn, Joo Hyuk
    Shin, Sang Joon
    Oh, Do-Youn
    Keam, Bhumsuk
    Lee, Hyo Jin
    Canon, Jean-Luc
    Kalinka-Warzocha, Ewa
    Langenberg, Marlies
    Allison, James
    Ben, Yong
    Kataria, Ritesh
    Ferro, Salvatore
    Asubonteng, Kobby
    Dirix, Luc
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [25] Cohort study of metastatic and unresectable, locally advanced urothelial carcinoma
    Rexer, Heidrun
    Schnabel, Marco J.
    Retz, Margitta
    AKTUELLE UROLOGIE, 2024, 55 (03)
  • [26] Immunotherapy with checkpoint inhibitors in local advanced and metastatic urothelial carcinoma
    Miller, Kurt
    Gschwend, Juergen E.
    Merseburger, Axel
    Retz, Margitta
    Stenzl, Arnulf
    AKTUELLE UROLOGIE, 2018, 49 (02) : 142 - 156
  • [27] Immunotherapy for advanced or metastatic urothelial carcinoma: an abridged Cochrane review
    Maisch, Philipp
    Hwang, Eu Chang
    Kim, Kwangmin
    Narayan, Vikram M.
    Bakker, Caitlin
    Kunath, Frank
    Dahm, Philipp
    BJU INTERNATIONAL, 2024, 134 (04) : 541 - 550
  • [28] Gemcitabine plus docetaxel as first-line biweekly therapy in locally advanced and/or metastatic urothelial carcinoma: a phase II study
    Neri, Bruno
    Vannini, Laura
    Giordano, Clara
    Grifoni, Raffaella
    Pantaleo, Pietro
    Baldazzi, Valentina
    Crisci, Alfonso
    Lapini, Alberto
    Raugei, Andrea
    Carini, Marco
    ANTI-CANCER DRUGS, 2007, 18 (10) : 1207 - 1211
  • [29] Cabozantinib plus pembrolizumab as first-line therapy for cisplatin-ineligible advanced urothelial carcinoma (PemCab).
    Jain, Rohit K.
    Swami, Umang
    Bilen, Mehmet Asim
    Boucher, Kenneth M.
    Brown, Jacqueline T.
    Chahoud, Jad
    Gupta, Sumati
    Agarwal, Neeraj
    Sonpavde, Guru P.
    Maughan, Benjamin L.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 539 - 539
  • [30] Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
    Powles, Thomas
    Park, Se Hoon
    Voog, Eric
    Caserta, Claudia
    Valderrama, Begona P.
    Gurney, Howard
    Kalofonos, Haralabos
    Radulovic, Sinisa
    Demey, Wim
    Ullen, Anders
    Loriot, Yohann
    Sridhar, Srikala S.
    Tsuchiya, Norihiko
    Kopyltsov, Evgeny
    Sternberg, Cora N.
    Bellmunt, Joaquim
    Aragon-Ching, Jeanny B.
    Petrylak, Daniel P.
    Laliberte, Robert
    Wang, Jing
    Huang, Bo
    Davis, Craig
    Fowst, Camilla
    Costa, Nuno
    Blake-Haskins, John A.
    di Pietro, Alessandra
    Grivas, Petros
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (13): : 1218 - 1230
12345